Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 I-Mab Appoints BD SVP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

I-Mab Appoints BD SVP

Fernando J. Sallés will be responsible for leading global out-licensing efforts and co-development partnerships/strategic alliances

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

I-Mab has appointment of Fernando J. Sallés, Ph.D., CLP, as senior vice president, head of U.S. & EU Business Development. In this newly created role, Dr. Sallés will initially be responsible for leading global out-licensing efforts and co-development partnerships/strategic alliances with large pharma and biopharma companies to expedite the development and market entry of the company’s products. Dr. Sallés will report to Dr. Jingwu Zang, Founder and Honorary Chairman of I-Mab, as a member of the senior executive team.

Dr. Sallés has more than 28 years of experience in academic and corporate research and development, including 19 years of building extensive networks in the pharma and biotech industries. He has extensive experience across the entire range of business development activities in several large, global pharma/biotech organizations, including in pipeline strategy, portfolio management, due diligence, transaction negotiations, in- and out-licenses, collaborations and M&A.

“Dr. Sallés is an industry veteran with broad experience across the business development lifecycle. We are very pleased to welcome Dr. Sallés to join our journey where he will lead our strategic efforts to broaden our global out-licensing and co-development partnerships of our internally developed innovative assets,” said Dr. Jingwu Zang, I-Mab’s Founder and Honorary Chairman of the Board.

Prior to joining I-Mab, Dr. Sallés provided business development expertise to buy-side and sell-side biopharma clients at Pteropsida, LLC. Before Pteropsida, Dr. Sallés was Vice President, Head of Global Search at Teva Pharmaceuticals, where he developed search organization strategies to complement and fill Teva’s branded R&D portfolio, including the identification and diligence on more than 50 executed licenses and M&A agreements, and out-licensing assets totaling an estimated $1 billion in value.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters